Assess Bioequivalence of One 150 mg Risedronate Tablet Versus Two 75 mg Risedronate Tablets in Healthy Subjects
Clinical trial NCT00699777 · COMPLETED
Trial details
- NCT number
- NCT00699777
- Sponsor
- Warner Chilcott
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2008-02-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.